With Decisions Worth Billions
MAKING THE RIGHT ONES MATTER
“Captario's ability to model strategic options and compare them in real-time is very powerful. The tool has helped us to generate exciting new opportunities and ideas about how we can optimize our development program and make ALZ-101 even more attractive to potential partners.”
Kristina Torfgård, CEO Alzinova
Alzinova is a Swedish biopharma company developing disease-modifying
treatments for Alzheimer’s disease.